Matches in Wikidata for { <http://www.wikidata.org/entity/Q102154382> ?p ?o ?g. }
Showing items 1 to 39 of
39
with 100 items per page.
- Q102154382 description "clinical trial" @default.
- Q102154382 description "ensayo clínico" @default.
- Q102154382 description "ensayu clínicu" @default.
- Q102154382 description "klinisch onderzoek" @default.
- Q102154382 description "клінічне випробування" @default.
- Q102154382 description "临床试验" @default.
- Q102154382 name "PD-L1 Antibody Combined With CTLA-4 Antibody for Patients With Advanced Intrahepatic Cholangiocarcinoma Who Progressed After Standard Treatment" @default.
- Q102154382 name "PD-L1 Antibody Combined With CTLA-4 Antibody for Patients With Advanced Intrahepatic Cholangiocarcinoma Who Progressed After Standard Treatment" @default.
- Q102154382 type Item @default.
- Q102154382 label "PD-L1 Antibody Combined With CTLA-4 Antibody for Patients With Advanced Intrahepatic Cholangiocarcinoma Who Progressed After Standard Treatment" @default.
- Q102154382 label "PD-L1 Antibody Combined With CTLA-4 Antibody for Patients With Advanced Intrahepatic Cholangiocarcinoma Who Progressed After Standard Treatment" @default.
- Q102154382 prefLabel "PD-L1 Antibody Combined With CTLA-4 Antibody for Patients With Advanced Intrahepatic Cholangiocarcinoma Who Progressed After Standard Treatment" @default.
- Q102154382 prefLabel "PD-L1 Antibody Combined With CTLA-4 Antibody for Patients With Advanced Intrahepatic Cholangiocarcinoma Who Progressed After Standard Treatment" @default.
- Q102154382 P1050 Q102154382-986BD0EB-82DE-4E86-9393-29D41DC3A888 @default.
- Q102154382 P1132 Q102154382-0D4DE4BC-6FFC-4644-BCEE-D6BA188A127C @default.
- Q102154382 P1476 Q102154382-3D5C841C-BF7C-44B8-A878-DA34981F6D62 @default.
- Q102154382 P2899 Q102154382-AFF43588-A7F4-458E-B2D7-8009EE1B2556 @default.
- Q102154382 P3098 Q102154382-8AEF7A6B-5BCF-48D6-A993-A0D1AE2C513E @default.
- Q102154382 P31 Q102154382-909B14DE-CD1B-4DC2-A0E6-6DA1FC8BBDE7 @default.
- Q102154382 P4844 Q102154382-C1A1F456-4428-4492-9DA3-62ABBB3A4654 @default.
- Q102154382 P580 Q102154382-242C69A0-3FF7-4572-84D4-3C0136EC3012 @default.
- Q102154382 P582 Q102154382-A55995B6-5373-4BB3-8B38-D4CE9A944851 @default.
- Q102154382 P6099 Q102154382-A6DAFB48-8A30-409C-9C17-C5B019FB9C8B @default.
- Q102154382 P6153 Q102154382-CFF5F1CD-AC08-4143-92DF-FBC6024BDB37 @default.
- Q102154382 P8005 Q102154382-AB0952E8-A27C-49EB-B808-225B00787401 @default.
- Q102154382 P8363 Q102154382-2A8FE2C2-31B3-4A6E-9EE6-8754CF5FEF1B @default.
- Q102154382 P1050 Q124292 @default.
- Q102154382 P1132 "+40" @default.
- Q102154382 P1476 "PD-L1 Antibody Combined With CTLA-4 Antibody for Patients With Advanced Intrahepatic Cholangiocarcinoma Who Progressed After Standard Treatment: a Single-arm, Phase II Clinical Study" @default.
- Q102154382 P2899 "+18" @default.
- Q102154382 P3098 "NCT04634058" @default.
- Q102154382 P31 Q30612 @default.
- Q102154382 P4844 Q66559285 @default.
- Q102154382 P580 "2020-11-01T00:00:00Z" @default.
- Q102154382 P582 "2022-09-01T00:00:00Z" @default.
- Q102154382 P6099 Q42824440 @default.
- Q102154382 P6153 Q10875263 @default.
- Q102154382 P8005 Q76649614 @default.
- Q102154382 P8363 Q78089383 @default.